Tibor Keler - Net Worth and Insider Trading

Tibor Keler Net Worth

The estimated net worth of Tibor Keler is at least $266,765 dollars as of 2024-04-26. Tibor Keler is the EXECUTIVE VP & CSO of Celldex Therapeutics Inc and owns about 7,357 shares of Celldex Therapeutics Inc (CLDX) stock worth over $266,765. Details can be seen in Tibor Keler's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Tibor Keler has not made any transactions after 2022-12-07 and currently still holds the listed stock(s).

Transaction Summary of Tibor Keler

To

Tibor Keler Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Tibor Keler owns 1 companies in total, including Celldex Therapeutics Inc (CLDX) .

Click here to see the complete history of Tibor Keler’s form 4 insider trades.

Insider Ownership Summary of Tibor Keler

Ticker Comapny Transaction Date Type of Owner
CLDX Celldex Therapeutics Inc 2022-12-07 Sen. VP & Ch Scientific Off.

Tibor Keler Latest Holdings Summary

Tibor Keler currently owns a total of 1 stock. Tibor Keler owns 7,357 shares of Celldex Therapeutics Inc (CLDX) as of December 7, 2022, with a value of $266,765.

Latest Holdings of Tibor Keler

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CLDX Celldex Therapeutics Inc 2022-12-07 7,357 36.26 266,765

Holding Weightings of Tibor Keler


Tibor Keler Form 4 Trading Tracker

According to the SEC Form 4 filings, Tibor Keler has made a total of 2 transactions in Celldex Therapeutics Inc (CLDX) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Celldex Therapeutics Inc is the sale of 16,860 shares on December 7, 2022, which brought Tibor Keler around $622,640.

Insider Trading History of Tibor Keler

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Tibor Keler Trading Performance

GuruFocus tracks the stock performance after each of Tibor Keler's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Tibor Keler is 57.95%. GuruFocus also compares Tibor Keler's trading performance to market benchmark return within the same time period. The performance of stocks bought by Tibor Keler within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Tibor Keler's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Tibor Keler

Average Return

169.22%

Average return per transaction

Outperforming Transactions

40%

2 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 84.4 57.95 102.34 169.22 61.22 54.16
Relative Return to S&P 500(%) 83.52 52.07 92.73 154.53 47.91 40.45

Tibor Keler Ownership Network

Ownership Network List of Tibor Keler

No Data

Ownership Network Relation of Tibor Keler


Tibor Keler Owned Company Details

What does Celldex Therapeutics Inc do?

Who are the key executives at Celldex Therapeutics Inc?

Tibor Keler is the Sen. VP & Ch Scientific Off. of Celldex Therapeutics Inc. Other key executives at Celldex Therapeutics Inc include SVP of Corp. Affairs & Admin. Sarah Cavanaugh , SVP & Chief Medical Officer Diane C. Young , and director & President and CEO Anthony S Marucci .

Celldex Therapeutics Inc (CLDX) Insider Trades Summary

Over the past 18 months, Tibor Keler made 1 insider transaction in Celldex Therapeutics Inc (CLDX) with a net sale of 16,860.

In summary, during the past 3 months, insiders sold 0 shares of Celldex Therapeutics Inc (CLDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 16,860 shares of Celldex Therapeutics Inc (CLDX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 16,860 shares.

Celldex Therapeutics Inc (CLDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Celldex Therapeutics Inc Insider Transactions

No Available Data

Tibor Keler Mailing Address

Above is the net worth, insider trading, and ownership report for Tibor Keler. You might contact Tibor Keler via mailing address: 30 Park Road, Ottsville Pa 18942.

Discussions on Tibor Keler

No discussions yet.